Forum Topic Diagnostics
  • Conversation: Intellectual property considerations for molecular diagnostic development with emphasis on companion diagnostics

    • July 20, 2018 4:28 PM BST
      • Post(s)
        10

      Intellectual property considerations for molecular diagnostic development with emphasis on companion diagnostics

      Introduction: The development of molecular diagnostics is a complex endeavor, with multiple regulatory pathways to consider and numerous approaches to development and commercialization. Companion diagnostics, devices which are “essential for the safe and effective use of a corresponding drug or diagnostic product” (see U.S. Food & Drug Administration, In Vitro Diagnostics - Companion Diagnostics, U.S. Dept. of Health & Human Services(2016), available at https://www.fda.gov/medicaldevices/productsandmedicalprocedures/invitrodiagnostics/ucm407297.htm) and complementary diagnostics, which are more broadly associated with a class of drug, are becoming increasingly important as integral components of the implementation of precision medicine.
      Continue Reading: https://www.tandfonline.com/doi/full/10.1080/13543776.2018.1409209

Add Reputation

Do you want to add reputation for this member by this post?

or cancel